Difference between revisions of "Ubiquitin"
m |
m |
||
(3 intermediate revisions by one other user not shown) | |||
Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
− | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
|- | |- | ||
− | | align="center" colspan="2" bgcolor="#ffffff" | [[Image: | + | | align="center" colspan="2" bgcolor="#ffffff" | [[Image:Ubiquitin.JPG|200px|{{PAGENAME}}]] |
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
Line 26: | Line 26: | ||
|- | |- | ||
| Reactive lysines | | Reactive lysines | ||
− | | [[ | + | | [[TG2 reactive residues (Ubiquitin)|K29, K48]] |
|- | |- | ||
| Substrate sequence | | Substrate sequence | ||
Line 37: | Line 37: | ||
|- | |- | ||
| Surface accessibility | | Surface accessibility | ||
− | | [http://gibk21.bse.kyutech.ac.jp/asaview/all/ | + | | [http://gibk21.bse.kyutech.ac.jp/asaview/all/1ubq.pdf ASAView] pdf |
+ | [http://gibk21.bse.kyutech.ac.jp/asaview/all/1ubq.txt ASAView] txt | ||
|- | |- | ||
| Disorder prediction | | Disorder prediction | ||
Line 48: | Line 49: | ||
| | | | ||
|- | |- | ||
− | | {{infobox header | + | |Video |
+ | |{{#ev:dailymotion|4JPyhK9WSVyWskY20|300}} | ||
+ | |- | ||
+ | | {infobox header} | | ||
|- | |- | ||
|} | |} | ||
[[Category:Tissue transglutaminase|*]] | [[Category:Tissue transglutaminase|*]] |
Latest revision as of 12:00, 10 March 2015
Ubiquitin | |
---|---|
Substrate peptide name | Ubiquitin |
Synonyms | - |
Determination type | In vitro |
Source | Homo sapiens |
Subcellular localization | Cytosol |
Swissprot ID | P62988 |
Reactive glutamines | - |
Reactive lysines | K29, K48 |
Substrate sequence | ENVKAKIQDKE
LIFAGKELRDG |
Structure | 1UBQ |
Surface accessibility | ASAView pdf
ASAView txt |
Disorder prediction | IUPred |
Reference | PMID:15132984 |
Notes | |
Video | 4JPyhK9WSVyWskY20|300}} |